Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Flow cytometry is a technology that simultaneously measures and then analyses multiple physical characteristics of single particles, usually cells, as they flow in a fluid stream through a beam of light. The properties measured include a particle’s relative size, relative granularity or internal complexity, and relative fluorescence intensity. These characteristics are determined using an optical-to-electronic coupling system that records how the cell or particle scatters incident laser light and emits fluorescence. Flow cytometry has evolved from a promising new technology to an indispensable tool for the diagnosis of several disorders, especially haematological malignancies. This technique has been successfully incorporated in the fields of computer science, laser technology, monoclonal antibody production, cytochemistry and fluorochrome chemistry.
The global flow cytometry market is witnessing significant growth owing to factors such as increasing adoption of flow cytometry techniques in research activities & clinical trials, budding focus on immunology & immuno-oncology research, high prevalence of AIDS & cancer and availability of novel application-specific flow cytometry products. Moreover, the overall market is also being propelled by growth in stem cell research coupled with adoption of recombinant DNA technology for antibody production. Furthermore, surging market penetration in emerging countries and evolution of tandem flow cytometry technologies would further provide significant growth opportunities to this market. However, the market is hampered by high cost of flow cytometry instruments and insufficient knowledge regarding the use of flow cytometers.
The report analyses the global flow cytometry market based on technology, product, application, end user and geography.
Based on technology, the market is categorized into cell-based and bead-based flow cytometry. Cell-based flow cytometry assays are used in drug discovery and clinical studies including tumour cells in peripheral blood, endothelial cells in blood, tumour stem cells, and hematopoietic progenitor cells. Furthermore, they are also used in the study of disease mechanism and target identification. Whereas, the bead-based technology has the capacity to detect multiple analytes and has high reproducibility, stability and speed.
Based on product, the market is categorized into reagents & consumables, instruments, software, services and accessories. The instruments used for flow cytometry are cell analysers, cell sorters, and sample preparation devices such as platforms for cell analysis & replaceable components like filters, lasers, and detectors. The introduction of novel technologies such as multicolour flow cytometers coupled with the capability to detect up to 18 cell parameters simultaneously has contributed significantly towards the market growth. Furthermore, the expansion in cytogenetic analysis capacity has prompted the consumption of reagents and various cell dissociation kits involved in cytometry.
The flow cytometry market has applications in research, clinical and industrial sectors. In research, the cytometers are used in pharmaceuticals & biotechnology, cell cycle analysis, cell viability, cell counting, immunology, cell sorting, apoptosis and other research applications. Also, in the clinical applications they are widely used in cancer, organ transplantation, immunodeficiency and haematology applications. New methods and tools of flow cytometry are allowing researchers to employ this powerful technique to make significant discoveries about stem cell and corresponding lineages.
Several end users of this market are hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies and academic & research institutes. The commercial organizations use flow cytometers across various verticals such as food microbiology, blood banks and plant cell culture. Moreover, the introduction of multiplex probes and reagents for precise applications in diagnostics & drug discovery is expected to propel the market in coming years.
By geography, the global flow cytometry market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America accounted for the market largest share in 2018. Availability of supportive government policies for the development of advanced flow cytometry technologies is the key growth drivers of this market in this region. Moreover, the Asia Pacific is expected to show lucrative growth during the forecast period due to expansion of research infrastructure, economic development and intensifying patient awareness levels.
The leading market players of the global flow cytometry market are Agilent Technologies, Apogee Flow Systems, Beckman Coulter (Danaher), Becton, Dickinson and Company, Biomérieux S.A., Bio-Rad Laboratories, Cytonome St, Enzo Life Sciences (Enzo Biochem, Inc.), Luminex, Merck KGaA, Miltenyi Biotec, Sony Biotechnology (Sony Corporation of America), Stratedigm and Sysmex Partec (Sysmex Corporation).
The global flow cytometry market is segmented based on technology, product, application, end user and geography. Based on technology, the market is categorized into cell-based and bead-based flow cytometry. Cell-based flow cytometry assays are used in drug discovery and clinical studies including tumour cells in peripheral blood, endothelial cells in blood, tumour stem cells, and hematopoietic progenitor cells.
Based on product, the market is categorized into reagents & consumables, instruments, software, services and accessories. The instruments used for flow cytometry are cell analysers, cell sorters, and sample preparation devices such as platforms for cell analysis & replaceable components like filters, lasers, and detectors.
The flow cytometry market has applications in research, clinical and industrial sectors. In research, the cytometers are used in pharmaceuticals & biotechnology, cell cycle analysis, cell viability, cell counting, immunology, cell sorting, apoptosis and other research applications. Also, in the clinical applications they are widely used in cancer, organ transplantation, immunodeficiency and haematology applications.
Several end users of this market are hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies and academic & research institutes. The commercial organizations use flow cytometers across various verticals such as food microbiology, blood banks and plant cell culture.
By geography, the global flow cytometry market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America accounted for the market largest share in 2018. Availability of supportive government policies for the development of advanced flow cytometry technologies is the key growth drivers of this market in this region.
Why to buy this report:
